Startups
Boragen is located in Research Triangle Park in Durham, N.C., and focuses on boron-based development of anti-bacterials and anti-fungicides for the agricultural industry.
BlueRock Therapeutics, which has locations in Toronto, NYC and Cambridge, Mass., rocketed to existence in December 2016 with $225M in venture funding to focus on regenerative medicine, using iPSC therapies.
Apostle, headquartered in Sunnyvale, Calif., hopes to file an IPO or establish other strong business collaborative routes in five years.
Based in Santa Clara, California, CBT Pharma was spun out of Crown Bioscience with four development-stage assets in the oncology space.
Tiny ITUS believes it is on track to develop a CAR-T treatment for solid tumors.
The financing was by Flagship Pioneering.
ImmunoMolecular Therapeputics officially launched yesterday.
Salaries and total compensation can range from $300,000 to $500,000 per year for these employees – whether they have a Ph.D. or are just out of college.
Kymera Therapeutics launched with a $30M Series A financing which was lead by Atlas Venture.
PRESS RELEASES